CXL®

The cornea is the soft dome on the top of the eye that refracts the light into the retina. However, the cornea over time may become thin and irregular in shape. This irregularity may be due to diseases such as keratoconus or be a result of previous eye surgery. The weakened cornea will not allow a sharp quality image and can progressively get worse over time. Corneal collagen cross-linking (CXL) is a procedure that uses Riboflavin and UV light to help strengthen a weakened cornea and in some cases reduce the need for rigid contacts or avoid a corneal transplant.

CXL has been widely used in Europe and Asia, nearly 400 centers throughout the world, and has been investigated since as early as 1988. It is not yet widely available in the U.S. as the combination therapy with UV light and Riboflavin is not specifically approved by the US Food and Drug Administration ("FDA"). Through a research study coordinated by the CXL-USA Study Group, Schwartz Laser Eye Center is now able to provide this breakthrough treatment to qualified patients.

This 30 minute, in office, procedure is achieved without cutting or removing any tissue from the cornea. Performing the surgery through the outer layer of the cornea, the epithelium, the surgery has quicker recovery, reduced risk of scarring, infection or unwanted haze.

CXL is currently being performed at Schwartz Laser Eye center on patients that have been diagnosed with keratoconus, pellucid marginal degeneration, fluctuating vision from RK or an irregular corneal shape. If you think you may benefit from CXL call or email for a free consultation with Dr. Schwartz.

back to top